Robert G. Maki
Impact in
- Gastroenterology top 0.01%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.01%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Gastrointestinal Tumor Research and Treatment 97
-
- Sarcoma Diagnosis and Treatment 230
- Gastric Cancer Management and Outcomes 46
- Co-authors
- Cristina R. AntonescuSamuel SingerMurray F. BrennanRonald P. DeMatteoGeorge D. DemetriMargaret von MehrenDavid R. D’AdamoShreyaskumar Patel
- Journals
- Journal of Clinical Oncology (132 papers)Clinical Cancer Research (19 papers)Annals of Oncology (18 papers)Cancer (15 papers)European Journal of Cancer (12 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Robert G. Maki
371 papers receiving 25.7k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Gastroenterology 8.0k
- Pulmonary and Respiratory Medicine 18.3k
- Oncology 9.7k
- Rheumatology 3.7k
- Neurology 2.8k
Countries citing papers authored by Robert G. Maki
This map shows the geographic impact of Robert G. Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Maki more than expected).
Fields of papers citing papers by Robert G. Maki
This network shows the impact of papers produced by Robert G. Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Maki. The network helps show where Robert G. Maki may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert G. Maki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 1 | |
| 4 | 2019 | 174 | |
| 5 | 2018 | 13 | |
| 6 | 2017 | 129 | |
| 7 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Hit paper breakdown → | 2015 | 576 |
| 8 | 2014 | 210 | |
| 9 | 2012 | 82 | |
| 10 | 2011 | 252 | |
| 11 | 2009 | 69 | |
| 12 | 2009 | 249 | |
| 13 | 2008 | 133 | |
| 14 | 2008 | 49 | |
| 15 | Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor Hit paper breakdown → | 2008 | 564 |
| 16 | 2008 | 187 | |
| 17 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Hit paper breakdown → | 2007 | 531 |
| 18 | 2007 | 189 | |
| 19 | 2007 | 77 | |
| 20 | 2004 | 250 |
About Robert G. Maki
Robert G. Maki is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Rheumatology, having authored 377 papers that have together received 26.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (230 papers), Gastrointestinal Tumor Research and Treatment (97 papers), Vascular Tumors and Angiosarcomas (83 papers), Cardiac tumors and thrombi (54 papers), Gastric Cancer Management and Outcomes (46 papers), Lymphoma Diagnosis and Treatment (33 papers), Neurofibromatosis and Schwannoma Cases (21 papers) and Soft tissue tumors and treatment (21 papers). The work is most often cited by research in Gastroenterology (8.0k citations), Pulmonary and Respiratory Medicine (18.3k citations), Oncology (9.7k citations), Rheumatology (3.7k citations) and Neurology (2.8k citations). Robert G. Maki has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Cristina R. Antonescu, Samuel Singer, Murray F. Brennan, Ronald P. DeMatteo, George D. Demetri, Margaret von Mehren, David R. D’Adamo, Shreyaskumar Patel, Peter Besmer and Peter W. T. Pisters. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.